Pictured: Breast tumor treated with paclitaxel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 2, 2011

Recent findings by Memorial Sloan-Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Pictured: David Solit
In the Lab
By Media Staff  |  Wednesday, November 23, 2011

Research led by investigators at Memorial Sloan-Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

Pictured: Evelyn Lauder
In Memoriam
By Memorial Sloan-Kettering  |  Monday, November 14, 2011

Memorial Sloan-Kettering mourns the loss of Evelyn H. Lauder, who was a tireless cancer research advocate and a member of our Board of Overseers.

Center News

Subscribe to Our E-newsletter

Get the latest information about cancer care.